BRME1
geneOn this page
Also known as MGC11271MEIOK21
Summary
BRME1 (break repair meiotic recombinase recruitment factor 1, HGNC:28153) is a protein-coding gene on chromosome 19p13.12, encoding Break repair meiotic recombinase recruitment factor 1 (Q0VDD7). Meiotic recombination factor component of recombination bridges involved in meiotic double-strand break repair.
Predicted to enable damaged DNA binding activity. Predicted to be involved in meiosis I; protein localization to site of double-strand break; and spermatogenesis. Predicted to be located in chromosome. Predicted to be active in site of double-strand break.
Source: NCBI Gene 79173 — RefSeq curated summary.
At a glance
- GWAS associations: 2
- Clinical variants (ClinVar): 23 total
- MANE Select transcript:
NM_001345843
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:28153 |
| Approved symbol | BRME1 |
| Name | break repair meiotic recombinase recruitment factor 1 |
| Location | 19p13.12 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | MGC11271, MEIOK21 |
| Ensembl gene | ENSG00000132016 |
| Ensembl biotype | protein_coding |
| OMIM | 619276 |
| Entrez | 79173 |
Gene structure
Transcript identifiers
Ensembl transcripts: 14 — 11 protein_coding, 2 protein_coding_CDS_not_defined, 1 retained_intron
ENST00000346736, ENST00000585755, ENST00000586500, ENST00000586783, ENST00000588115, ENST00000589393, ENST00000591439, ENST00000591586, ENST00000871175, ENST00000871176, ENST00000871177, ENST00000871178, ENST00000871179, ENST00000968796
RefSeq mRNA: 10 — MANE Select: NM_001345843
NM_001345843, NM_001345844, NM_001345846, NM_001345847, NM_001345848, NM_001393645, NM_001393646, NM_001393647, NM_001393648, NM_024323
CCDS: CCDS12299, CCDS92535, CCDS92536
Canonical transcript exons
ENST00000586783 — 9 exons
| Exon | Start | End |
|---|---|---|
| ENSE00000902112 | 13885961 | 13886055 |
| ENSE00001055366 | 13889188 | 13890462 |
| ENSE00001239125 | 13892786 | 13892890 |
| ENSE00001239131 | 13893142 | 13893223 |
| ENSE00001239139 | 13895372 | 13895546 |
| ENSE00001369402 | 13904862 | 13904913 |
| ENSE00001749383 | 13883308 | 13883400 |
| ENSE00002797501 | 13882348 | 13882952 |
| ENSE00003922974 | 13905715 | 13906117 |
Expression profiles
Bgee: expression breadth ubiquitous, 134 present calls, max score 88.23.
FANTOM5 (CAGE): breadth broad, TPM avg 2.1391 / max 45.5164, expressed in 837 samples.
FANTOM5 promoters (4 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 179575 | 1.1426 | 555 |
| 179574 | 0.6285 | 306 |
| 179573 | 0.2002 | 76 |
| 179572 | 0.1678 | 81 |
Top tissues by expression
134 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| right testis | UBERON:0004534 | 88.23 | gold quality |
| left testis | UBERON:0004533 | 87.61 | gold quality |
| testis | UBERON:0000473 | 86.94 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 86.22 | gold quality |
| mucosa of transverse colon | UBERON:0004991 | 84.80 | gold quality |
| sural nerve | UBERON:0015488 | 84.48 | gold quality |
| ventricular zone | UBERON:0003053 | 83.34 | gold quality |
| ganglionic eminence | UBERON:0004023 | 82.73 | gold quality |
| cortical plate | UBERON:0005343 | 81.54 | gold quality |
| right hemisphere of cerebellum | UBERON:0014890 | 80.39 | gold quality |
| lower esophagus mucosa | UBERON:0035834 | 80.11 | gold quality |
| cerebellar hemisphere | UBERON:0002245 | 79.97 | gold quality |
| cerebellum | UBERON:0002037 | 79.92 | gold quality |
| cerebellar cortex | UBERON:0002129 | 79.86 | gold quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 79.55 | gold quality |
| body of pancreas | UBERON:0001150 | 79.13 | gold quality |
| esophagus mucosa | UBERON:0002469 | 78.55 | gold quality |
| skin of abdomen | UBERON:0001416 | 78.39 | gold quality |
| duodenum | UBERON:0002114 | 78.27 | gold quality |
| zone of skin | UBERON:0000014 | 77.92 | gold quality |
| skin of leg | UBERON:0001511 | 77.63 | gold quality |
| small intestine Peyer’s patch | UBERON:0003454 | 76.64 | gold quality |
| small intestine | UBERON:0002108 | 76.31 | gold quality |
| vagina | UBERON:0000996 | 75.88 | gold quality |
| transverse colon | UBERON:0001157 | 75.71 | gold quality |
| tibial nerve | UBERON:0001323 | 75.37 | gold quality |
| right uterine tube | UBERON:0001302 | 75.16 | gold quality |
| right frontal lobe | UBERON:0002810 | 74.67 | gold quality |
| ectocervix | UBERON:0012249 | 74.37 | gold quality |
| C1 segment of cervical spinal cord | UBERON:0006469 | 74.33 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 1.86 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
21 targeting BRME1, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-3662 | 99.99 | 73.82 | 5684 |
| HSA-MIR-5696 | 99.98 | 72.36 | 4487 |
| HSA-MIR-3688-3P | 99.97 | 72.02 | 2834 |
| HSA-MIR-570-3P | 99.96 | 72.41 | 4910 |
| HSA-MIR-185-3P | 99.95 | 67.01 | 1743 |
| HSA-MIR-4496 | 99.88 | 68.89 | 2236 |
| HSA-MIR-4694-3P | 99.79 | 69.53 | 2640 |
| HSA-MIR-3150A-3P | 99.76 | 64.44 | 1640 |
| HSA-MIR-6763-5P | 99.76 | 64.68 | 1767 |
| HSA-MIR-4729 | 99.69 | 72.18 | 4233 |
| HSA-MIR-5093 | 99.67 | 69.26 | 2291 |
| HSA-MIR-3175 | 99.65 | 66.30 | 2031 |
| HSA-MIR-4786-3P | 99.36 | 68.35 | 1390 |
| HSA-MIR-12113 | 99.32 | 67.54 | 1072 |
| HSA-MIR-6799-5P | 99.14 | 65.72 | 2093 |
| HSA-MIR-4539 | 98.78 | 67.18 | 888 |
| HSA-MIR-6878-5P | 98.49 | 67.91 | 2142 |
| HSA-MIR-1233-5P | 98.19 | 66.71 | 1201 |
| HSA-MIR-6778-5P | 98.19 | 66.59 | 1239 |
| HSA-MIR-432-5P | 98.00 | 68.13 | 989 |
| HSA-MIR-4442 | 92.35 | 67.08 | 98 |
Cross-species orthologs
2 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| mus_musculus | Brme1 | ENSMUSG00000008129 |
| rattus_norvegicus | Brme1 | ENSRNOG00000025796 |
Protein
Protein identifiers
Break repair meiotic recombinase recruitment factor 1 — Q0VDD7 (reviewed: Q0VDD7)
Alternative names: Pre-T/NK cell-associated protein 3B3
All UniProt accessions (4): Q0VDD7, K7ELK3, K7EMZ7, K7EP60
UniProt curated annotations — full annotation on UniProt →
Function. Meiotic recombination factor component of recombination bridges involved in meiotic double-strand break repair. Modulates the localization of recombinases DMC1:RAD51 to meiotic double-strand break (DSB) sites through the interaction with and stabilization of the BRCA2:HSF2BP complex during meiotic recombination. Indispensable for the DSB repair, homologous synapsis, and crossover formation that are needed for progression past metaphase I, is essential for spermatogenesis and male fertility.
Subunit / interactions. Interacts with HSF2BP (via N-terminus) and BRCA2; the interaction with HSF2BP is direct and allows the formation of a ternary complex. The complex BRME1:HSF2BP:BRCA2 interacts with SPATA22, MEIOB and RAD51.
Subcellular location. Chromosome.
Isoforms (2)
| UniProt ID | Names | Canonical? |
|---|---|---|
| Q0VDD7-1 | 1 | yes |
| Q0VDD7-2 | 2 |
RefSeq proteins (10): NP_001332772, NP_001332773, NP_001332775, NP_001332776, NP_001332777, NP_001380574, NP_001380575, NP_001380576, NP_001380577, NP_077299 (=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR031441 | Brme1 | Family |
Pfam: PF15710
UniProt features (18 total): compositionally biased region 6, region of interest 5, sequence variant 2, chain 1, modified residue 1, splice variant 1, sequence conflict 1, helix 1
Structure
Experimental structures (PDB)
1 structures.
| PDB | Method | Resolution (Å) |
|---|---|---|
| 8A51 | X-RAY DIFFRACTION | 1.9 |
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q0VDD7-F1 | 47.23 | 0.04 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Post-translational modifications (1): 370
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 107 (showing top):
E2F_Q4, E2F4DP1_01, GOBP_MALE_GAMETE_GENERATION, GGGTGGRR_PAX4_03, E2F1DP1_01, E2F1DP2_01, GOBP_ORGANELLE_FISSION, GOBP_DNA_DAMAGE_RESPONSE, GOBP_FEMALE_GAMETE_GENERATION, E2F1_Q3, GOBP_DEVELOPMENTAL_PROCESS_INVOLVED_IN_REPRODUCTION, GOBP_MEIOTIC_CELL_CYCLE_PROCESS, TAL1BETAE47_01, MODULE_112, MYB_Q5_01
GO Biological Process (4): female meiosis I (GO:0007144), spermatogenesis (GO:0007283), double-strand break repair involved in meiotic recombination (GO:1990918), meiotic cell cycle (GO:0051321)
GO Molecular Function (1): protein binding (GO:0005515)
GO Cellular Component (1): chromosome (GO:0005694)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| meiosis I | 1 |
| female meiotic nuclear division | 1 |
| female gamete generation | 1 |
| meiotic cell cycle | 1 |
| developmental process involved in reproduction | 1 |
| male gamete generation | 1 |
| double-strand break repair | 1 |
| reciprocal meiotic recombination | 1 |
| meiotic cell cycle process | 1 |
| cell cycle | 1 |
| sexual reproduction | 1 |
| reproductive process | 1 |
| meiotic nuclear division | 1 |
| binding | 1 |
| intracellular membraneless organelle | 1 |
Protein interactions and networks
STRING
262 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| BRME1 | HSF2BP | O75031 | 760 |
| BRME1 | SPATA22 | Q8NHS9 | 620 |
| BRME1 | MEIOB | Q8N635 | 609 |
| BRME1 | C19orf67 | A6NJJ6 | 541 |
| BRME1 | SYCP3 | Q8IZU3 | 470 |
| BRME1 | SYCE2 | Q6PIF2 | 418 |
| BRME1 | HORMAD2 | Q8N7B1 | 409 |
| BRME1 | HORMAD1 | Q86X24 | 406 |
| BRME1 | C19orf53 | Q9UNZ5 | 400 |
| BRME1 | SPO11 | Q9Y5K1 | 394 |
| BRME1 | RNF212 | Q495C1 | 390 |
| BRME1 | C14orf39 | Q8N1H7 | 379 |
| BRME1 | ADGRE3 | Q9BY15 | 374 |
| BRME1 | FAM222A | Q5U5X8 | 371 |
| BRME1 | SWSAP1 | Q6NVH7 | 370 |
IntAct
99 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| AIMP2 | BRME1 | psi-mi:“MI:0915”(physical association) | 0.830 |
| BRME1 | AIMP2 | psi-mi:“MI:0915”(physical association) | 0.830 |
| TRIM23 | BRME1 | psi-mi:“MI:0915”(physical association) | 0.670 |
| KRTAP10-9 | BRME1 | psi-mi:“MI:0915”(physical association) | 0.670 |
| BRME1 | TRIM23 | psi-mi:“MI:0915”(physical association) | 0.670 |
| BRME1 | KRTAP10-9 | psi-mi:“MI:0915”(physical association) | 0.670 |
| PSMA6 | BRME1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| RUNX1T1 | BRME1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| BRME1 | psi-mi:“MI:0915”(physical association) | 0.560 | |
| BRME1 | KRT38 | psi-mi:“MI:0915”(physical association) | 0.560 |
| BRME1 | KRTAP10-7 | psi-mi:“MI:0915”(physical association) | 0.560 |
| BRME1 | KRT40 | psi-mi:“MI:0915”(physical association) | 0.560 |
| BRME1 | HAUS3 | psi-mi:“MI:0915”(physical association) | 0.560 |
| HOMER1 | BRME1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| FAM9B | BRME1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| BRME1 | TSC22D3 | psi-mi:“MI:0915”(physical association) | 0.560 |
| CTNNAL1 | BRME1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| BRME1 | PSMA6 | psi-mi:“MI:0915”(physical association) | 0.560 |
| BRME1 | RUNX1T1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| BRME1 | psi-mi:“MI:0915”(physical association) | 0.560 |
BioGRID (54): C19orf57 (Two-hybrid), C19orf57 (Two-hybrid), C19orf57 (Two-hybrid), C19orf57 (Two-hybrid), C19orf57 (Two-hybrid), C19orf57 (Two-hybrid), C19orf57 (Two-hybrid), C19orf57 (Two-hybrid), HAUS3 (Two-hybrid), KRT40 (Two-hybrid), FAM9B (Two-hybrid), KRTAP10-7 (Two-hybrid), KRTAP10-9 (Two-hybrid), KRTAP10-3 (Two-hybrid), C19orf25 (Two-hybrid)
ESM2 similar proteins: A0A096LP49, A0A8V8TNH8, A0A8V8TPE2, A6NDY2, A6NIJ5, A6NJQ4, A6NKC0, A6NNH2, A6NNJ1, A8MUA0, A8MWA6, A8MX19, A8MXJ8, A8MXZ1, A8MYA2, B1ASB6, D6RGX4, P0C7V4, P0C7W8, P0C7W9, P0C7X0, P0DV73, P0DV74, P0DV75, P0DV76, Q0VDD7, Q2KIS6, Q3UHD3, Q4R736, Q5SZB4, Q5T8A7, Q5VZ46, Q5XIK6, Q658T7, Q6A025, Q6NTE8, Q6PIX9, Q6ZMY3, Q86Y26, Q86YD7
Diamond homologs: Q0VDD7, Q6DIA7
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
23 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 6 |
| Likely benign | 4 |
| Benign | 1 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
2106 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 19:13882894:T:TA | donor_gain | 1.0000 |
| 19:13883306:A:AC | donor_gain | 1.0000 |
| 19:13883307:C:CC | donor_gain | 1.0000 |
| 19:13883309:T:TA | donor_gain | 1.0000 |
| 19:13892891:C:CC | acceptor_gain | 1.0000 |
| 19:13892899:C:CT | acceptor_gain | 1.0000 |
| 19:13892902:A:AC | acceptor_gain | 1.0000 |
| 19:13892917:A:T | acceptor_gain | 1.0000 |
| 19:13904857:CGTA:C | donor_loss | 1.0000 |
| 19:13904858:GTA:G | donor_loss | 1.0000 |
| 19:13904859:TAC:T | donor_loss | 1.0000 |
| 19:13904860:A:AC | donor_gain | 1.0000 |
| 19:13904861:C:A | donor_loss | 1.0000 |
| 19:13904861:C:CC | donor_gain | 1.0000 |
| 19:13904913:TC:T | acceptor_loss | 1.0000 |
| 19:13904915:T:G | acceptor_loss | 1.0000 |
| 19:13882877:G:A | donor_gain | 0.9900 |
| 19:13882880:T:TA | donor_gain | 0.9900 |
| 19:13882881:C:A | donor_gain | 0.9900 |
| 19:13882953:C:CC | acceptor_gain | 0.9900 |
| 19:13883080:A:C | donor_gain | 0.9900 |
| 19:13883307:CTT:C | donor_gain | 0.9900 |
| 19:13883326:A:C | donor_gain | 0.9900 |
| 19:13883406:C:CT | acceptor_gain | 0.9900 |
| 19:13883407:A:T | acceptor_gain | 0.9900 |
| 19:13885956:CCTA:C | donor_loss | 0.9900 |
| 19:13885957:CTA:C | donor_loss | 0.9900 |
| 19:13885959:ACC:A | donor_loss | 0.9900 |
| 19:13885960:C:CA | donor_loss | 0.9900 |
| 19:13892779:GCCTT:G | donor_loss | 0.9900 |
AlphaMissense
4311 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 19:13883320:A:G | L615P | 0.991 |
| 19:13882950:C:G | R620P | 0.990 |
| 19:13882929:C:G | R627P | 0.986 |
| 19:13883311:A:G | L618P | 0.986 |
| 19:13883332:A:G | L611P | 0.984 |
| 19:13892861:A:C | F106L | 0.984 |
| 19:13892861:A:T | F106L | 0.984 |
| 19:13892863:A:G | F106L | 0.984 |
| 19:13892873:A:C | F102L | 0.981 |
| 19:13892873:A:T | F102L | 0.981 |
| 19:13892875:A:G | F102L | 0.981 |
| 19:13882947:A:G | L621P | 0.977 |
| 19:13883320:A:T | L615H | 0.977 |
| 19:13882940:C:A | M623I | 0.976 |
| 19:13882940:C:G | M623I | 0.976 |
| 19:13882940:C:T | M623I | 0.976 |
| 19:13883317:G:A | S616F | 0.969 |
| 19:13883318:A:G | S616P | 0.968 |
| 19:13882923:A:G | L629P | 0.967 |
| 19:13883323:T:A | E614V | 0.967 |
| 19:13882944:A:T | I622N | 0.965 |
| 19:13882910:C:A | K633N | 0.964 |
| 19:13882910:C:G | K633N | 0.964 |
| 19:13882952:G:C | N619K | 0.964 |
| 19:13882952:G:T | N619K | 0.964 |
| 19:13882944:A:C | I622S | 0.963 |
| 19:13883336:C:G | G610R | 0.963 |
| 19:13882933:G:C | H626D | 0.961 |
| 19:13883320:A:C | L615R | 0.961 |
| 19:13883332:A:T | L611H | 0.960 |
dbSNP variants (sampled 300 via entrez): RS1000018074 (19:13902990 T>C), RS1000199459 (19:13883530 G>A), RS1000317030 (19:13903302 A>G), RS1000453134 (19:13887149 G>A), RS1000484174 (19:13891949 T>A,C), RS1000566290 (19:13886154 G>A,C), RS1000825751 (19:13897879 A>G), RS1000919214 (19:13904552 C>T), RS1001091248 (19:13898293 T>C), RS1001187639 (19:13902720 T>A,G), RS1001329092 (19:13903785 T>C), RS1001435114 (19:13904279 C>G), RS1001785693 (19:13886583 C>T), RS1001816780 (19:13886326 C>T), RS1001853407 (19:13892184 A>C,G)
Disease associations
OMIM: gene MIM:619276 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
2 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST010816_9 | Gut microbiota beta diversity (weighted UniFrac distance) | 2.000000e-06 |
| GCST012335_32 | Hodgkin’s lymphoma | 9.000000e-11 |
EFO canonical traits (1, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0007874 | gut microbiome measurement |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
16 total (human), top 16 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| sodium arsenite | increases expression | 2 |
| aristolochic acid I | increases expression | 1 |
| GSK-J4 | decreases expression | 1 |
| FR900359 | decreases phosphorylation | 1 |
| bisphenol A | affects cotreatment, increases methylation | 1 |
| tris(1,3-dichloro-2-propyl)phosphate | decreases expression | 1 |
| aflatoxin B2 | increases methylation | 1 |
| (+)-JQ1 compound | decreases expression | 1 |
| Fulvestrant | affects cotreatment, increases methylation | 1 |
| Arsenic | affects methylation | 1 |
| Benzo(a)pyrene | affects methylation | 1 |
| Caffeine | decreases phosphorylation | 1 |
| Tobacco Smoke Pollution | decreases expression | 1 |
| Aflatoxin B1 | increases methylation | 1 |
| Okadaic Acid | increases expression | 1 |
| Acrylamide | decreases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
- Disease cohort memberships (association, not causation — diseases whose associated-gene cohort lists this gene; a subset are also under Associated diseases): Hodgkins lymphoma